Nucli Experts Competitors

About Genomic Health Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-based diagnostic tests that help optimize cancer care by addressing the overtreatment of the disease, one of the greatest issues in healthcare today. With its Oncotype IQ® Genomic Intelligence Platform, the company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of clinical and genomic big data into actionable results for treatment planning throughout the cancer patient journey, from diagnosis to treatment selection and monitoring. The Oncotype IQ portfolio of genomic tests and services currently consists of the company's flagship line of Oncotype DX gene expression tests that have been used to guide treatment decisions for more than 750,000 cancer patients worldwide. Genomic Health is expanding its test portfolio to include additional liquid- and tissue-based tests, including the recently launched Oncotype SEQ® Liquid Select™ test. The company is based in Redwood City, California, with international headquarters in Geneva, Switzerland. For more information, please visit, www.GenomicHealth.com and follow the company on Twitter: @GenomicHealth, Facebook, YouTube and LinkedIn. About Oncotype DX® The Oncotype DX® portfolio of breast, colon and prostate cancer tests applies advanced genomic science to reveal the unique biology of a tumor in order to optimize cancer treatment decisions. The company's flagship product, the Oncotype DX Breast Recurrence Score®, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer. Additionally, the Oncotype DX Breast DCIS Score™ predicts the likelihood of recurrence in a pre-invasive form of breast cancer called DCIS. In prostate cancer, the Oncotype DX Genomic Prostate Score™ predicts disease aggressiveness and further clarifies the current and future risk of the cancer prior to treatment intervention. With more than 750,000 patients tested in more than 90 countries, the Oncotype DX tests have redefined personalized medicine by making genomics a critical part of cancer diagnosis and treatment. To learn more about Oncotype DX tests, visit www.OncotypeIQ.com, www.MyBreastCancerTreatment.org or www.MyProstateCancerTreatment.org.

REGENESIS is the global leader in technology-based solutions for the environment with an emphasis on contaminated site remediation. Started in 1994, the Company has developed a range of widely-used specialty chemicals for the proven and low-cost cleanup of contaminated soil and groundwater. Environmental consulting firms around the world have successfully used Regenesis technologies on thousands of polluted sites ranging from large Department of Defense and Superfund Projects to corner gas stations and dry cleaning operations. Over the years Regenesis has developed an unmatched breadth and depth of experience with enhanced bioremediation, in-situ chemical oxidation, ex-situ soils treatment, bioaugmentation and a range of remediation application methodologies.

Nexagen is ISO: 9001:2008, ISO 9001:2015, ISO/IEC 20000-1:2018, ISO/IEC 27001:2013 Economically Disadvantaged Woman Owned Small Business (EDWOSB). We provide support in Digitization and Modernization (DevSecOps and Cloud Engineering), Satellite Communications, Cybersecurity, Systems and Software Engineering, Software Development Life Cycle (SDLC), RF Engineering, Project Management, Network Engineering, Logistics, and COMSEC. How Nexagen can work for you: Project Management: Planning, organizing, motivating, and controlling resources, procedures and protocols to achieve specific goals and solve problems. Information Assurance: Assuring information and managing risks related to the use, processing, storage, and transmission of information or data and the systems and processes used for those purposes. System Engineering: Focusing on how to design and manage complex engineering projects over their life cycles. Software Engineering: Developing and maintaining software systems that behave reliably and efficiently, are affordable, and satisfy all the requirements that customers have defined for them. Network Engineering: Implementing, maintaining, supporting, developing and, in some cases designing, communication networks within or between organizations to ensure the integrity and high availability network infrastructure in order to provide maximum performance for their users, such as staff, clients, customers and suppliers. RF Engineering: Providing or controlling coverage with some kind of antenna/transmission system and generating or receiving signals to or from that transmission system to other communications electronics or controls.